The Sunday Guardian Live on MSN
Vitruvias Therapeutics thyroid drug recall elevated to FDA's highest-risk Class I level - what it means
India, Sept. 24 -- Vitruvias Therapeutics Inc. announced on 21 August a nationwide consumer-level recall of Lot 504950 of Thyroid Tablets, USP 30 mg, after laboratory testing confirmed the tablets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results